03:13 AM EDT, 03/19/2025 (MT Newswires) -- Yann Mazabraud, Executive Vice President, Head of International, on March 14, 2025, sold 75,000 shares in Rhythm Pharmaceuticals ( RYTM ) for $3,861,272. Following the Form 4 filing with the SEC, Mazabraud has control over a total of 40,370 common shares of the company, with 40,370 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465925025236/xslF345X05/tm259548-1_4seq1.xml